Agape ATP Corp
ATPC0.111USD
+0.003+2.78%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
5.56MMarket Cap
LossP/E TTM
More Details of Agape ATP Corp Company
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
Agape ATP Corp Info
Ticker SymbolATPC
Company nameAgape ATP Corp
IPO dateSep 17, 2018
CEOHow (Kok Choong)
Number of employees16
Security typeOrdinary Share
Fiscal year-endSep 17
Address1705-1708 Level 17, Tower 2, Faber Tower
CityKUALA LUMPUR
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryMalaysia
Postal code58100
Phone60327325716
Websitehttps://www.agapeatpgroup.com/index_php
Ticker SymbolATPC
IPO dateSep 17, 2018
CEOHow (Kok Choong)
Company Executives of Agape ATP Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Kok Choong How
Dr. Kok Choong How
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
--
--
Mr. Kam Fan (Andrew) Lee
Mr. Kam Fan (Andrew) Lee
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tjong Budisantoso, Ph.D.
Mr. Tjong Budisantoso, Ph.D.
Executive Director
Executive Director
--
--
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Director
Director
--
--
Ms. Rose Marie Kadende Marie Kadende Kaiser
Ms. Rose Marie Kadende Marie Kadende Kaiser
Independent Director
Independent Director
--
--
Dr. Ni Luh Dharmakert Natih
Dr. Ni Luh Dharmakert Natih
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Kok Choong How
Dr. Kok Choong How
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
--
--
Mr. Kam Fan (Andrew) Lee
Mr. Kam Fan (Andrew) Lee
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tjong Budisantoso, Ph.D.
Mr. Tjong Budisantoso, Ph.D.
Executive Director
Executive Director
--
--
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Director
Director
--
--
Ms. Rose Marie Kadende Marie Kadende Kaiser
Ms. Rose Marie Kadende Marie Kadende Kaiser
Independent Director
Independent Director
--
--
Dr. Ni Luh Dharmakert Natih
Dr. Ni Luh Dharmakert Natih
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Others – Products for the provision of complementary health therapies
218.65K
46.97%
Green energy
135.43K
29.09%
Skin care and healthcare products
55.45K
11.91%
Health and wellness services
39.82K
8.55%
Energized Mineral Concentrate
13.77K
2.96%
Other
2.38K
0.51%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Others – Products for the provision of complementary health therapies
218.65K
46.97%
Green energy
135.43K
29.09%
Skin care and healthcare products
55.45K
11.91%
Health and wellness services
39.82K
8.55%
Energized Mineral Concentrate
13.77K
2.96%
Other
2.38K
0.51%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lesser Panda Ltd
7.36%
Global Fartech Ltd
6.90%
Nexus Investments Group Ltd
6.07%
Oceanic Equity Partner Ltd
6.06%
Blue Horizon Capital Ltd
6.05%
Other
67.57%
Shareholders
Shareholders
Proportion
Lesser Panda Ltd
7.36%
Global Fartech Ltd
6.90%
Nexus Investments Group Ltd
6.07%
Oceanic Equity Partner Ltd
6.06%
Blue Horizon Capital Ltd
6.05%
Other
67.57%
Shareholder Types
Shareholders
Proportion
Corporation
51.30%
Individual Investor
1.97%
Hedge Fund
0.15%
Venture Capital
0.02%
Investment Advisor
0.02%
Other
46.54%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
12
96.83K
0.35%
--
2025Q3
12
96.83K
0.35%
-72.67K
2025Q2
11
169.49K
0.02%
+164.03K
2025Q1
9
5.47K
0.16%
-73.08K
2024Q4
8
71.66K
0.86%
+46.14K
2024Q3
8
25.52K
0.25%
+18.90K
2024Q2
7
6.62K
0.25%
-3.05K
2024Q1
6
9.68K
0.06%
+7.38K
2023Q4
1
578.00
0.00%
+578.00
2023Q3
2
1.39M
36.92%
--
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lesser Panda Ltd
3.68M
7.36%
+3.68M
--
Mar 24, 2025
Global Fartech Ltd
3.45M
6.9%
+3.45M
--
Mar 24, 2025
Nexus Investments Group Ltd
3.04M
6.07%
+3.04M
--
Mar 24, 2025
Oceanic Equity Partner Ltd
3.03M
6.06%
+3.03M
--
Mar 24, 2025
Blue Horizon Capital Ltd
3.03M
6.05%
+3.03M
--
Mar 24, 2025
Global Ascend Ventures Ltd
3.02M
6.04%
+3.02M
--
Mar 24, 2025
Vanguard Development Holdings Ltd
3.02M
6.03%
+3.02M
--
Mar 24, 2025
Evergreen Strategic Capital Holding Ltd
3.01M
6.03%
+3.01M
--
Mar 24, 2025
Choong (How Kok)
980.45K
1.96%
+574.00
+0.06%
Jan 08, 2025
HKC Talent, Ltd
385.75K
0.77%
-26.50K
-6.43%
Jan 08, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Date
Type
Ratio
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
FAQs
Who are the top five shareholders of Agape ATP Corp?
The top five shareholders of Agape ATP Corp are:
Lesser Panda Ltd holds 3.68M shares, accounting for 7.36% of the total shares.
Global Fartech Ltd holds 3.45M shares, accounting for 6.90% of the total shares.
Nexus Investments Group Ltd holds 3.04M shares, accounting for 6.07% of the total shares.
Oceanic Equity Partner Ltd holds 3.03M shares, accounting for 6.06% of the total shares.
Blue Horizon Capital Ltd holds 3.03M shares, accounting for 6.05% of the total shares.
Lesser Panda Ltd holds 3.68M shares, accounting for 7.36% of the total shares.
Global Fartech Ltd holds 3.45M shares, accounting for 6.90% of the total shares.
Nexus Investments Group Ltd holds 3.04M shares, accounting for 6.07% of the total shares.
Oceanic Equity Partner Ltd holds 3.03M shares, accounting for 6.06% of the total shares.
Blue Horizon Capital Ltd holds 3.03M shares, accounting for 6.05% of the total shares.
What are the top three shareholder types of Agape ATP Corp?
The top three shareholder types of Agape ATP Corp are:
Lesser Panda Ltd
Global Fartech Ltd
Nexus Investments Group Ltd
Lesser Panda Ltd
Global Fartech Ltd
Nexus Investments Group Ltd
How many institutions hold shares of Agape ATP Corp (ATPC)?
As of 2025Q4, 12 institutions hold shares of Agape ATP Corp, with a combined market value of approximately 96.83K, accounting for 0.35% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.00%.
What is the biggest source of revenue for Agape ATP Corp?
In FY2025Q2, the Others – Products for the provision of complementary health therapies business generated the highest revenue for Agape ATP Corp, amounting to 218.65K and accounting for 46.97% of total revenue.
